Antimicrobial peptides (HNPs 1-3 and LL-37) as biomarkers of inflammatory process activity in children with H. pylori-associated duodenal ulcer
DOI:
https://doi.org/10.15574/SP.2022.126.49Keywords:
children, Helicobacter pylori, duodenal ulcer, inflammatory activity, antimicrobial peptides, HNPs 1-3, LL-37Abstract
Various gastrointestinal and extragastrointestinal diseases are associated with H. pylori in children and adolescents, but the strongest recommendations for testing and treatment are made only in children and adolescents with duodenal ulcer (DU). The inability of natural immune mechanisms to recognize and eliminate H. pylori leads to the development of acute inflammation. The most promising developments so far are studies of the antibacterial effect of endogenous antimicrobial peptides (AP), among which defensines 1-3 (human neutrophil peptides, HNPs 1-3) and cathelicidins (LL-37) are the most important for the human body.
Purpose - to investigate the concentration of HNPs 1-3 and LL-37 in the blood of children with DU in order to determine the activity of the inflammatory process of the mucous membrane.
Materials and methods. 65 children aged 7-18 years, suffering from DU and 25 healthy children of the corresponding age (comparison group) were examined. The level of HNPs 1-3 and LL-37 was determined in blood plasma by enzyme-linked immunosorbent assay according to the manufacturers instructions.
Results. Patients were divided by age, sex, location and size of the ulcer, presence of the H. pylori bacterium. A toxigenic strain of H. pylori was detected in 80.9% of examined children, and the level of HNPs 1-3 in blood plasma was 3 times higher and the level of LL-37 was 2.5 times higher in children with H. pylori-associated DU than in healthy children (p=0.01).
Concentrations of HNPs 1-3 and LL-37 in blood plasma were higher in patients with an active inflammatory process in the mucous membrane and were positively correlated with the degree of inflammation activity (r=0.67, p=0.05 and r=0.69, p=0.01). After eradication therapy, AP levels decrease, while the degree of decrease directly depends on the activity of the inflammatory process.
Conclusions. Probably higher concentrations of HNPs 1-3 and LL-37 were found in the blood plasma of children with H. pylori-associated DU. Considering the direct correlations between the levels of HNPs 1-3 and LL-37 and the degree of activity of the inflammatory process, these indicators can be used as biomarkers of the adverse course of H. pylori-associated DU.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Amerikova M, Pencheva El-Tibi I, Maslarska V, Bozhanov S, Tachkov K. (2019). Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents. Biotechnology & Biotechnological Equipment. 33 (1): 671-682. https://doi.org/10.1080/13102818.2019.1611385
Biernat MM, Bińkowska A, Łaczmański Ł, Biernat P, Krzyżek P, Gościniak G. (2020). Phenotypic and Genotypic Analysis of Resistant Helicobacter pylori Strains Isolated from Children with Gastrointestinal Diseases. Diagnostics (Basel). 10 (10): 759. https://doi.org/10.3390/diagnostics10100759; PMid:32992661 PMCid:PMC7601641
Czaplewski L, Bax R, Clokie M et al. (2016). Alternatives to antibiotics a pipeline portfolio review. Lancet Infect Dis. 16 (2): 239-251. https://doi.org/10.1016/S1473-3099(15)00466-1; PMid:26795692
Daugule I, Karklina D, Rudzite D, Remberga S, Rumba-Rozenfelde I. (2016). Prevalence of Helicobacter pylori infection among preschool children in Latvia: no significant decrease in prevalence during a 10 years period. Scand J Public Health. 44 (4): 418-422. https://doi.org/10.1177/1403494816631861; PMid:26862127
Dixon BR, Radin JN, Piazuelo MB, Contreras DC. Algood HM. (2016). L-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori. PLoS ONE. 11: e0148514. https://doi.org/10.1371/journal.pone.0148514; PMid:26867135 PMCid:PMC4750979
Dudnikova EV, Badyan AS, Nesterova EV, Besedina EA. (2020). The role of β2-defensin in the development of chronic gastritis in children. Pediatrics. 99 (5): 16-21. https://doi.org/10.24110/0031-403X-2020-99-5-16-21
Idowu A, Mzukwa A, Harrison U et al. (2019). Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa. BMC Gastroenterol. 19: 73. https://doi.org/10.1186/s12876-019-0986-0; PMid:31088381 PMCid:PMC6518451
Isomoto H, Mukae H, Ishimoto H et al. (2004). Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am J Gastroenterol. 99 (10): 1916-1923. https://doi.org/10.1111/j.1572-0241.2004.40334.x; PMid:15447750
Isomoto H, Mukae H, Ishimoto H et al. (2005). High concentrations of human β-defensin 2 in gastric juice of patients with Helicobacter pylori infection. World J Gastroenterol. 11: 4782-4787. https://doi.org/10.3748/wjg.v11.i31.4782; PMid:16097044 PMCid:PMC4398722
Jiang Y, Chen Y, Song Z, Tan Z, Cheng J. (2021). Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation. Advanced. Drug Delivery Reviews. 170: 261-280. https://doi.org/10.1016/j.addr.2020.12.016; PMid:33400958
Kienesberger S, Perez-Perez GI, Olivares AZ et al. (2018). When is Helicobacter pylori acquired in populations in developing countries? A birth-cohort study in Bangladeshi children. Gut Microbes. 9 (3): 252-263. https://doi.org/10.1080/19490976.2017.1421887; PMid:29494270 PMCid:PMC6219588
Kotilea K, Kalach N, Homan M, Bontems P. (2018). Helicobacter pylori infection in pediatric patients: update on diagnosis and eradication strategies. Paediatr Drugs. 20: 337-351. https://doi.org/10.1007/s40272-018-0296-y; PMid:29785564
Kudryashova E, Quintyn R, Seveau S, Lu W, Wysocki VH, Kudryashov DS. (2014). Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins. Immunity. 41: 709-721. https://doi.org/10.1016/j.immuni.2014.10.018; PMid:25517613 PMCid:PMC4269836
Leja M, Grinberga‐Derica I, Bilgilier C et al. (2019). Epidemiology of Helicobacter pylori infection. Helicobacter. 24: e12635. https://doi.org/10.1111/hel.12635; PMid:31486242
Ministry of Health of Ukraine. (2013). Order of MOH Ukraine of 29.01.2013 No. 59. Unified clinical protocols of medical care for children with diseases of the digestive system (Regulations Ministry of Health of Ukraine).
Munch D, Sahl HG. (2015). Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides. Biochim Biophys Acta. 1848; 11 Pt B: 3062-3071. https://doi.org/10.1016/j.bbamem.2015.04.014; PMid:25934055
Nishi Y, Isomoto H, Mukae H et al. (2005). Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases. World J Gastroenterol. 11 (1): 99-103. https://doi.org/10.3748/wjg.v11.i1.99; PMid:15609405 PMCid:PMC4205393
Okuda M, Lin Y, Kikuchi S. (2019). Helicobacter pylori infection in children and adolescents. Helicobacter pylori in Human Diseases. 1149: 107-120. https://doi.org/10.1007/5584_2019_361; PMid:31037557
Pero R, Brancaccio M, Laneri S, Biasi MG, Lombardo B, Scudiero O. (2019). Novel View of Human Helicobacter pylori Infections: Interplay between Microbiota and Beta-Defensins. Biomolecules. 9 (6): 237. https://doi.org/10.3390/biom9060237; PMid:31216758 PMCid:PMC6627275
Rosu OM, Gimiga N, Stefanescu G et al. (2022). Helicobacter pylori Infection in a Pediatric Population from Romania: Risk Factors, Clinical and Endoscopic Features and Treatment Compliance. J Clin Med. 11 (9): 2432. https://doi.org/10.3390/jcm11092432; PMid:35566557 PMCid:PMC9099726
Sorokman TV, Chernei NY, Sokolnyk SV et al. (2020). Efficacy of eradication therapy in children with H Pylori-associated diseases depending on levels of nitric oxide and vitamin D. Medical Science. 2 (104): 895-1903.
Sorokman TV, Moldova PM, Makarova ОV. (2020). Prospects for the use of antimicrobial peptides as antihelicobacterial agents in pediatric practice. Modern Pediatrics. Ukraine. 8 (112): 47-54. https://doi.org/10.15574/SP.2020.112.47
Sorokman TV, Moldovan PM. (2019). Chronic inflammatory bowel disease in children: modern invasive and non-invasive diagnosis. Modern Pediatrics.Ukraine. 6 (102): 99-105. https://doi.org/10.15574/SP.2019.102.99
Sorokman TV, Sokolnyk SV, Moldovan PM, Chernei NYa, Ostapchuk VG. (2022). Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori. Wiadomości Lekarskie. LXXV, 1 (2): 71-78. https://doi.org/10.36740/WLek202201212; PMid:35182125
Soylu OB, Ozturk Y, Ozer E. (2008). Alpha-defensin expression in the gastric tissue of children with Helicobacter pylori-associated chronic gastritis: an immunohistochemical study. J. Pediatr. Gastroenterol. Nutr. 46 (4): 474-477. https://doi.org/10.1097/MPG.0b013e31815a9923; PMid:18367969
Taha AS, Faccenda E, Angerson WJ, Balsitis M, Kelly RW. (2005). Gastric epithelial anti-microbial peptides-histological correlation and influence of anatomical site and peptic ulcer disease. Dig. Liver Dis. 37: 51-56. https://doi.org/10.1016/j.dld.2004.07.019; PMid:15702860
Valere K, Lu W, Chang TL. (2017). Key determinants of human alpha-defensin 5 and 6 for enhancement of HIV infectivity. Viruses. 9: 244. https://doi.org/10.3390/v9090244; PMid:28850095 PMCid:PMC5618010
Van Harten RM, van Woudenbergh E, van Dijk A, Haagsman HP. (2018). Cathelicidins: Immunomodulatory Antimicrobials. Vaccines (Basel). 6 (3): 63. https://doi.org/10.3390/vaccines6030063; PMid:30223448 PMCid:PMC6161271
Vordenbäumen S, Pilic D, Otte JM, Schmitz F, Schmidt-Choudhury A. (2010). Defensin-mRNA expression in the upper gastrointestinal tract is modulated in children with celiac disease and Helicobacter pylori-positive gastritis. J Pediatr Gastroenterol Nutr. 50 (6): 596-600. https://doi.org/10.1097/MPG.0b013e3181cd26cd; PMid:20400909
Xu C, Wu Y, Xu S. (2022). Association between Helicobacter pylori infection and growth outcomes in children: A meta-analysis. Helicobacter. 27 (1): e12861. https://doi.org/10.1111/hel.12861; PMCid:PMC9542484
Yokota S, Konno M, Fujiwara S et al. (2015). Intrafamilial, preferentially mother-to-child and intraspousal, Helicobacter pylori infection in Japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting. Helicobacter. 20: 334-342. https://doi.org/10.1111/hel.12217; PMid:25664889
Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, Derakhshan MH. (2018). Systematic review with meta-analysis: The worldwide prevalence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 47: 868-876. https://doi.org/10.1111/apt.14561; PMid:29430669
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
